Evidence map›Paper›PMID 40502643›Full record

ArticleRadiology case reports2025

Recurrent presacral tailgut cyst with mucinous adenocarcinoma and metastasis.

Iyad Al Jada, Majd Oweidat, Mohammad Khaleel, Omar Harb, Ursula Abu Nahla, Rahaf Bleibel, Mai Arafeh, Ammar W M Hassouneh

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iyad Al JadaCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Majd OweidatCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Mohammad KhaleelCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Omar HarbCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Ursula Abu NahlaCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Rahaf BleibelCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Mai ArafehCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Ammar W M HassounehCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tailgut cysts (TGCs) are rare congenital lesions arising from incomplete regression of the embryonic hindgut, typically located in the presacral space and more common in females. Although often benign, these cysts carry a risk of malignant transformation. We report a case of a woman in her early 50s who presented with abdominal pain, urinary retention, and tenesmus. Initial imaging revealed a large presacral cystic lesion, and incomplete surgical excision confirmed benign histology. However, the patient returned 6 months later with recurrent symptoms and new-onset lower limb weakness. Repeat imaging showed a recurrent cystic lesion with liver and bony metastases. MRI showed peripheral nodular enhancement of the lesion and enhancing bone lesions. A liver biopsy confirmed mucinous adenocarcinoma. Despite chemotherapy, the disease progressed rapidly, and the patient passed away within 2 months. This case highlights the potential for malignant degeneration in TGCs, which, though rare, carries significant morbidity. Complete surgical resection and follow-up are critical to prevent recurrence and malignancy risk. Further research is needed to study the malignant transformation predictors of this rare entity.

Indexed as

Malignant degenerationMetastasisMucinous adenocarcinomaTailgut cyst

Identifiers

PMID40502643
PMCPMC12155624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.